Raymond James & Associates’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-325
| Closed | -$4K | – | 3499 |
|
|
2018
Q3 | $4K | Sell |
325
-25
| -7% | -$308 | ﹤0.01% | 3492 |
|
|
2018
Q2 | $96K | Sell |
350
-567
| -62% | -$156K | ﹤0.01% | 3371 |
|
|
2018
Q1 | $249K | Buy |
917
+242
| +36% | +$65.7K | ﹤0.01% | 2991 |
|
|
2017
Q4 | $161K | Sell |
675
-491
| -42% | -$117K | ﹤0.01% | 3096 |
|
|
2017
Q3 | $236K | Sell |
1,166
-441
| -27% | -$89.3K | ﹤0.01% | 2922 |
|
|
2017
Q2 | $186K | Buy |
1,607
+600
| +60% | +$69.4K | ﹤0.01% | 2976 |
|
|
2017
Q1 | $161K | Buy |
1,007
+700
| +228% | +$112K | ﹤0.01% | 2951 |
|
|
2016
Q4 | $53K | Sell |
307
-63
| -17% | -$10.9K | ﹤0.01% | 3023 |
|
|
2016
Q3 | $90K | Hold |
370
| – | – | ﹤0.01% | 2966 |
|
|
2016
Q2 | $92K | Sell |
370
-6
| -2% | -$1.49K | ﹤0.01% | 2794 |
|
|
2016
Q1 | $136K | Buy |
+376
| New | +$136K | ﹤0.01% | 2652 |
|
|
2015
Q3 | – | Sell |
-397
| Closed | -$335K | – | 2324 |
|
|
2015
Q2 | $335K | Buy |
397
+31
| +8% | +$26.2K | ﹤0.01% | 2240 |
|
|
2015
Q1 | $366K | Buy |
+366
| New | +$366K | ﹤0.01% | 2144 |
|